Paolo Gubellini

Summary

Country: France

Publications

  1. ncbi Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
    Paolo Gubellini
    Equipe IC2N, Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216, 31, Chemin Joseph Aiguier CNRS Université de la Méditerranée, 13402 Marseille, Cedex 20, France
    Eur J Neurosci 24:1802-14. 2006
  2. ncbi Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior
    Paolo Gubellini
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 CNRS Université de la Méditerranée, Case 907, Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France
    Prog Neurobiol 89:79-123. 2009
  3. ncbi Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases
    Paolo Gubellini
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 CNRS Université de la Méditerranée, Marseille, France
    Biochim Biophys Acta 1802:151-61. 2010
  4. ncbi Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
    Corinne Beurrier
    Institut de Biologie du Developpement de Marseille Luminy, UMR 6216 CNRS Université de la Méditerranée, Marseille, France
    FASEB J 23:3619-28. 2009
  5. ncbi Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease
    Christelle Baunez
    Laboratoire de Neurobiologie de la Cognition LNC, UMR6155 CNRS Aix Marseille Université, Marseille, France
    Prog Brain Res 183:235-58. 2010
  6. ncbi Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake
    Corinne Beurrier
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 Centre National de la Recherche Scientifique Université de la Méditerranée, Marseille, France
    PLoS ONE 5:e8550. 2010
  7. ncbi Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment
    Dario Cuomo
    Institut de Biologie du Developpement de Marseille Luminy, UMR6216 CNRS, Universite de la Mediterranee, Marseille, France
    J Neurochem 109:1096-105. 2009

Collaborators

Detail Information

Publications7

  1. ncbi Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
    Paolo Gubellini
    Equipe IC2N, Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216, 31, Chemin Joseph Aiguier CNRS Université de la Méditerranée, 13402 Marseille, Cedex 20, France
    Eur J Neurosci 24:1802-14. 2006
    ..The interaction between these two treatments provides further evidence that striatal glutamatergic hyperactivity is a pathophysiological correlate of akinesia rather than LID...
  2. ncbi Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior
    Paolo Gubellini
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 CNRS Université de la Méditerranée, Case 907, Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France
    Prog Neurobiol 89:79-123. 2009
    ....
  3. ncbi Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases
    Paolo Gubellini
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 CNRS Université de la Méditerranée, Marseille, France
    Biochim Biophys Acta 1802:151-61. 2010
    ....
  4. ncbi Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
    Corinne Beurrier
    Institut de Biologie du Developpement de Marseille Luminy, UMR 6216 CNRS Université de la Méditerranée, Marseille, France
    FASEB J 23:3619-28. 2009
    ..Finally, systemic administration of LSP1-2111 counteracts haloperidol-induced catalepsy, opening promising perspectives for the development of antiparkinsonian therapeutic strategies focused on orthosteric mGlu4-receptor agonists...
  5. ncbi Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease
    Christelle Baunez
    Laboratoire de Neurobiologie de la Cognition LNC, UMR6155 CNRS Aix Marseille Université, Marseille, France
    Prog Brain Res 183:235-58. 2010
    ....
  6. ncbi Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake
    Corinne Beurrier
    Institut de Biologie du Developpement de Marseille Luminy IBDML, UMR6216 Centre National de la Recherche Scientifique Université de la Méditerranée, Marseille, France
    PLoS ONE 5:e8550. 2010
    ....
  7. ncbi Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment
    Dario Cuomo
    Institut de Biologie du Developpement de Marseille Luminy, UMR6216 CNRS, Universite de la Mediterranee, Marseille, France
    J Neurochem 109:1096-105. 2009
    ....